ATG Combined With Cyclophosphamide And Cord Blood Transfusion in Treating Patients With Severe Aplastic Anemia

Key facts

Sponsor

Jinan Military General Hospital

Principal Investigator

Fang Zhou, MD

The General Hospital Of Jinan Military Command

Intervention

Rabbit ATG, (Genzyme)(drug)

Enrollment

130 enrolled

Eligibility

1-60 years · All sexes

Timeline

2017 – 2019

Study locations (1)

• The General Hospital Of Jinan Military Command, Jinan, Shandong, China

Collaborators

Shandong University of Traditional Chinese Medicine · Jining Medical University · Weifang Medical University · Guangzhou First People's Hospital · Harbin Hematology and Oncology Institute · Jining First People's Hospital · JIANGXI Provincal People's Hospital · Jinhua Central Hospital · Linyi People's Hospital · Shandong Cord Blood Bank · Qingdao Hiser Medical Group · Qingdao University · Taian City Central Hospital · Yantai Yuhuangding Hospital · Yishui Central Hospital of LINYI · Institute of Hematology & Blood Diseases Hospital, China · Shengjing Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Aplastic Anemia

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT07461116
  Adverse Effects of ATG/ALG Therapy in Aplastic Anemia
  Institute of Hematology & Blood Diseases Hospital, China
• RECRUITINGPHASE2NCT07400341
  Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AA
  The First Affiliated Hospital of Soochow University
• RECRUITINGNANCT07101770
  A Prediction Model in Pregnant Women With Aplastic Anemia
  Peking University People's Hospital
• RECRUITINGNANCT07499284
  A Multicenter, Randomized, Open-Label Study of Haplo-Cord HSCT for the Treatment of Aplastic Anemia
  The First Affiliated Hospital of Soochow University
• RECRUITINGPHASE2NCT06752694
  Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic Anemia
  Fred Hutchinson Cancer Center
• RECRUITINGPHASE1NCT06622694
  CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic Anemia
  Institute of Hematology & Blood Diseases Hospital, China
• RECRUITINGPHASE2NCT06517641
  Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia
  Medical College of Wisconsin
• RECRUITINGNANCT06936930
  Reproductive and Mental Health of Patients With Aplastic Anemia
  Institute of Hematology & Blood Diseases Hospital, China

See all trials for Aplastic Anemia →